[Action required] Your RSS.app Trial has Expired.
Your trial has expired. Please update your subscription plan at rss.app. – (vA119n1AwqmQgNNT)
Category: Uncategorized
The global COVID-19 treatment divide
Experts warn of huge global inequities in access to new treatments for COVID-19. Ann Danaiya Usher reports.
Comparative efficacy and tolerability of 32 oral and long-acting injectable antipsychotics for the maintenance treatment of adults with schizophrenia: a systematic review and network meta-analysis
As we found no clear differences between antipsychotics for relapse prevention, we conclude that the choice of antipsychotic for maintenance treatment should […]
Prophylactic use of an anti-activated factor XII monoclonal antibody, garadacimab, for patients with C1-esterase inhibitor-deficient hereditary angioedema: a randomised, double-blind, placebo-controlled, phase 2 trial
Garadacimab 200 mg and 600 mg every 4 weeks significantly reduced the number of monthly attacks versus placebo and was well tolerated […]
Variation in the COVID-19 infection–fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis
Estimating the IFR for global populations helps to identify relative vulnerabilities to COVID-19. Information about how IFR varies by age, time, and […]
Our commitment to help accelerate progress against cancer
Cancer affects everyone, regardless of age, gender, or social status, and represents a tremendous burden for patients, families, and societies. In 2020, […]